Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Translational Psychiatry
|
February 19, 2020
ADHD and ASD: distinct brain patterns of inhibition-related activation?
Ariadna Albajara Sáenz, Mathilde Septier, Peter Van Schuerbeek, et al.
The Lancet. Neurology
|
September 18, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
Eugenio Mercuri, Francesco Muntoni, Giovanni Baranello, et al.
Neuromuscular Disorders : NMD
|
March 4, 2014
Diagnostic approach to the congenital muscular dystrophies
Carsten G Bönnemann, Ching H Wang, Susana Quijano-Roy, et al.
The Journal of Infectious Diseases
|
August 23, 2025
Genetic landscape of a cohort of children with varicella-zoster virus encephalitis, cerebellitis and stroke
Franziska Winzig, Kerstin De Keukeleere, Esther Bartholomeus, et al.
The New England Journal of Medicine
|
February 24, 2021
Risdiplam in Type 1 Spinal Muscular Atrophy
Giovanni Baranello, Basil T Darras, John W Day, et al.
Journal of Neuromuscular Diseases
|
March 14, 2026
Impairment of lip and tongue strength in symptomatic SMA1 patients: Results from a 4-center prospective study using the IOPI
Charlotte Colot, Federica Trucco, Pablo Ruiz Chicaiza, et al.
Brain : a Journal of Neurology
|
November 26, 2013
Natural history of pulmonary function in collagen VI-related myopathies
A Reghan Foley, Susana Quijano-Roy, James Collins, et al.
The Lancet. Neurology
|
September 12, 2014
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
Thomas Voit, Haluk Topaloglu, Volker Straub, et al.
Human Genomics
|
March 1, 2023
Congenital hydrocephalus: new Mendelian mutations and evidence for oligogenic inheritance
Valerie Jacquemin, Nassim Versbraegen, Sarah Duerinckx, et al.
Journal of Neurology
|
February 3, 2023
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)
Maryam Oskoui, John W Day, Nicolas Deconinck, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Translational Psychiatry
|
February 19, 2020
ADHD and ASD: distinct brain patterns of inhibition-related activation?
Ariadna Albajara Sáenz, Mathilde Septier, Peter Van Schuerbeek, et al.
The Lancet. Neurology
|
September 18, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
Eugenio Mercuri, Francesco Muntoni, Giovanni Baranello, et al.
Neuromuscular Disorders : NMD
|
March 4, 2014
Diagnostic approach to the congenital muscular dystrophies
Carsten G Bönnemann, Ching H Wang, Susana Quijano-Roy, et al.
The Journal of Infectious Diseases
|
August 23, 2025
Genetic landscape of a cohort of children with varicella-zoster virus encephalitis, cerebellitis and stroke
Franziska Winzig, Kerstin De Keukeleere, Esther Bartholomeus, et al.
The New England Journal of Medicine
|
February 24, 2021
Risdiplam in Type 1 Spinal Muscular Atrophy
Giovanni Baranello, Basil T Darras, John W Day, et al.
Journal of Neuromuscular Diseases
|
March 14, 2026
Impairment of lip and tongue strength in symptomatic SMA1 patients: Results from a 4-center prospective study using the IOPI
Charlotte Colot, Federica Trucco, Pablo Ruiz Chicaiza, et al.
Brain : a Journal of Neurology
|
November 26, 2013
Natural history of pulmonary function in collagen VI-related myopathies
A Reghan Foley, Susana Quijano-Roy, James Collins, et al.
The Lancet. Neurology
|
September 12, 2014
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
Thomas Voit, Haluk Topaloglu, Volker Straub, et al.
Human Genomics
|
March 1, 2023
Congenital hydrocephalus: new Mendelian mutations and evidence for oligogenic inheritance
Valerie Jacquemin, Nassim Versbraegen, Sarah Duerinckx, et al.
Journal of Neurology
|
February 3, 2023
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)
Maryam Oskoui, John W Day, Nicolas Deconinck, et al.
Page
of 8